
|Videos|April 26, 2022
ViaLase shares updates on new technology to treat glaucoma, company updates and upcoming trials
Author(s)Kassi Filkins
Tom Frinzi, executive chairman of ViaLase, a new company based in Orange County, gives an update on the company, sharing some exciting new things happening.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
EURETINA 2026: Uveitis or retinitis pigmentosa? Ester Carreño, MD, PhD, on mimics
2
EURETINA 2026: Retinal signs as diagnostic clues to systemic metabolic disease
3
EURETINA 2026: Gene therapy sessions to watch in Vienna
4
Gene therapy 4D-150 enters phase 3 in DME with 4SIGHT trial launch
5















